article thumbnail

Branding Diseases—How Drug Companies Market Psychiatric Conditions: An Interview with Ray Moynihan

Mad in America

Dhar: Is this what inspired you to create the “documentary” for ‘Motivational Deficiency Disorder’ and the April Fool piece in BMJ along with it? We investigated social anxiety disorder. Now, spilling forward 20 years, social anxiety disorder is an uncontroversial part of the medical establishment.

article thumbnail

Do Critics of Biological Psychiatry Have an Alternative to a Life of “Whack-A-Mole”?

Mad in America

This turn to ketamine is occurring despite the fact that the Food and Drug Administration has repeatedly warned that the FDA has not approved ketamine for the treatment of any psychiatric disorder (though controversially approving esketamine nasal spray). accepting personal or office gifts or corporate donations from industry.

article thumbnail

STAR*D: The Harms of Orchestrated Psychiatric Fraud

Mad in America

We showed how STAR*D’s authors had manipulated the data to manufacture fraudulent results. NIMH has spent many tens of billions of research dollars over many decades attempting to substantiate a physiological basis for depression and other mental disorders, only to come up empty handed.